Prostate Cancer

Roswell Park’s prostate team includes some of the nation’s leading physicians, surgeons and radiologists devoted to finding better treatment options for men diagnosed with prostate cancer. We are committed to working with you to establish a personalized care plan that is tailored to meet your individual needs.

Groundbreaking research by our faculty has led to major advances in prostate cancer early detection, diagnosis and treatment. Roswell Park pioneered the prostate-specific antigen (PSA) test that is used worldwide in the detection and management of prostate cancer.

Our physicians are part of the National Comprehensive Cancer Network (NCCN) Prostate Cancer Treatment Panel setting the standards for cancer care. The NCCN guidelines provide a framework for the best ways of detecting and treating prostate cancer based on scientific data.

Robot-assisted surgery and other minimally invasive techniques are now used to perform almost 100 percent of prostate cancer surgeries at RPCI. Our surgeons report that patients experience better outcomes: fewer post-surgical complications, reduced pain, shorter hospital stays and quicker recovery.

Roswell Park Cancer Institute has been named a 2017–18 Best Hospital for cancer by U.S. News & World Report and recognized as high-performing for urology.

Pioneering Clinical Trials

Roswell Park strives to find better ways to treat this disease through clinical trials, many of which have been pioneered and launched by our own translational research team.